blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4285895

EP4285895 - NITROFURANTOIN ORAL DOSAGE FORM [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  03.11.2023
Database last updated on 05.07.2024
Most recent event   Tooltip28.06.2024New entry: Application deemed to be withdrawn: despatch of communication + time limit 
Applicant(s)For all designated states
Adalvo Limited
Malta Life Science Park
Building 1 Level 4 / Sir Temi Zammit Buildings
San Gwann Industrial Estate
San Gwann, SGN 3000 / MT
[2023/49]
Inventor(s)01 / Kalmoua, Faysal
Oss / NL
02 / Feitzinger, Martina
Mondsee / AT
 [2023/49]
Representative(s)Harber IP s.r.o.
Dukelskych hrdinu 567/52
17000 Praha 7 / CZ
[2023/49]
Application number, filing date22177334.403.06.2022
[2023/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4285895
Date:06.12.2023
Language:EN
[2023/49]
Search report(s)(Supplementary) European search report - dispatched on:EP28.11.2022
ClassificationIPC:A61K9/48, A61K31/4178, A61K47/38, A61K47/42, A61K9/26, A61K47/32
[2023/49]
CPC:
A61K9/2027 (EP); A61K31/4178 (EP); A61K47/38 (EP);
A61K9/2077 (EP); A61K9/4808 (EP); A61K9/4816 (EP);
A61K9/4825 (EP); A61K9/4858 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/49]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ORALE DOSIERUNGSFORM VON NITROFURANTOIN[2023/49]
English:NITROFURANTOIN ORAL DOSAGE FORM[2023/49]
French:FORME POSOLOGIQUE ORALE DE NITROFURANTOÏNE[2023/49]
Examination procedure27.06.2024Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US4772473  (PATEL VIKRAM S [US], et al) [Y] 4,8-10,13,14 * column 12, line 55; table . * * column 12, line 20; example 5 * * claim 1 *;
 [A]US4777033  (IKURA HIROSHI [JP], et al) [A] 6,7* column 6, line 40 - line 49 *;
 [A]US2005202079  (BIELSKI TARA L [US], et al) [A] 1-14 * the whole document *;
 [XYI]US2006002997  (SHAMAR PUNEET [IN], et al) [X] 1-3,5,11,12 * paragraph [0034] - paragraph [0054]; examples 1, 2 * * paragraph [0055] - paragraph [0057]; tables 1, 2 * * paragraphs [0006] , [0007] , [0009] , [0010] , [0012] - [0016] - [0025] - [0030] - [0032] * [Y] 4,8-10,13,14 [I] 6,7
by applicantEP0250023
 EP0250038
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.